annual D&A:
$27.10M+$5.80M(+27.23%)Summary
- As of today (May 29, 2025), NBIX annual depreciation & amortization is $27.10 million, with the most recent change of +$5.80 million (+27.23%) on December 31, 2024.
- During the last 3 years, NBIX annual D&A has risen by +$16.20 million (+148.62%).
- NBIX annual D&A is now at all-time high.
Performance
NBIX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$7.60M+$500.00K(+7.04%)Summary
- As of today (May 29, 2025), NBIX quarterly depreciation & amortization is $7.60 million, with the most recent change of +$500.00 thousand (+7.04%) on March 31, 2025.
- Over the past year, NBIX quarterly D&A has increased by +$1.40 million (+22.58%).
- NBIX quarterly D&A is now at all-time high.
Performance
NBIX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$28.50M+$1.40M(+5.17%)Summary
- As of today (May 29, 2025), NBIX TTM depreciation & amortization is $28.50 million, with the most recent change of +$1.40 million (+5.17%) on March 31, 2025.
- Over the past year, NBIX TTM D&A has increased by +$6.00 million (+26.67%).
- NBIX TTM D&A is now at all-time high.
Performance
NBIX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NBIX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | +22.6% | +26.7% |
| 3 y3 years | +148.6% | +130.3% | +143.6% |
| 5 y5 years | +266.2% | +261.9% | +260.8% |
NBIX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.6% | at high | +130.3% | at high | +143.6% |
| 5 y | 5-year | at high | +266.2% | at high | +261.9% | at high | +260.8% |
| alltime | all time | at high | +4024.8% | at high | +5407.3% | at high | >+9999.0% |
NBIX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $7.60M(+7.0%) | $28.50M(+5.2%) |
| Dec 2024 | $27.10M(+27.2%) | $7.10M(+9.2%) | $27.10M(+5.4%) |
| Sep 2024 | - | $6.50M(-11.0%) | $25.70M(+4.0%) |
| Jun 2024 | - | $7.30M(+17.7%) | $24.70M(+9.8%) |
| Mar 2024 | - | $6.20M(+8.8%) | $22.50M(+5.6%) |
| Dec 2023 | $21.30M(+36.5%) | $5.70M(+3.6%) | $21.30M(+6.5%) |
| Sep 2023 | - | $5.50M(+7.8%) | $20.00M(+8.1%) |
| Jun 2023 | - | $5.10M(+2.0%) | $18.50M(+6.9%) |
| Mar 2023 | - | $5.00M(+13.6%) | $17.30M(+10.9%) |
| Dec 2022 | $15.60M(+43.1%) | $4.40M(+10.0%) | $15.60M(+9.9%) |
| Sep 2022 | - | $4.00M(+2.6%) | $14.20M(+9.2%) |
| Jun 2022 | - | $3.90M(+18.2%) | $13.00M(+11.1%) |
| Mar 2022 | - | $3.30M(+10.0%) | $11.70M(+7.3%) |
| Dec 2021 | $10.90M(+26.7%) | $3.00M(+7.1%) | $10.90M(+7.9%) |
| Sep 2021 | - | $2.80M(+7.7%) | $10.10M(+6.3%) |
| Jun 2021 | - | $2.60M(+4.0%) | $9.50M(+5.6%) |
| Mar 2021 | - | $2.50M(+13.6%) | $9.00M(+4.7%) |
| Dec 2020 | $8.60M(+16.2%) | $2.20M(0.0%) | $8.60M(+2.4%) |
| Sep 2020 | - | $2.20M(+4.8%) | $8.40M(+2.4%) |
| Jun 2020 | - | $2.10M(0.0%) | $8.20M(+3.8%) |
| Mar 2020 | - | $2.10M(+5.0%) | $7.90M(+6.8%) |
| Dec 2019 | $7.40M(+85.0%) | $2.00M(0.0%) | $7.40M(+11.3%) |
| Sep 2019 | - | $2.00M(+11.1%) | $6.65M(+16.1%) |
| Jun 2019 | - | $1.80M(+12.5%) | $5.73M(+19.0%) |
| Mar 2019 | - | $1.60M(+27.9%) | $4.81M(+20.3%) |
| Dec 2018 | $4.00M(+66.7%) | $1.25M(+15.8%) | $4.00M(+15.8%) |
| Sep 2018 | - | $1.08M(+22.3%) | $3.46M(+15.5%) |
| Jun 2018 | - | $883.00K(+12.3%) | $2.99M(+10.9%) |
| Mar 2018 | - | $786.00K(+11.3%) | $2.70M(+12.4%) |
| Dec 2017 | $2.40M(+65.2%) | $706.00K(+14.6%) | $2.40M(+12.2%) |
| Sep 2017 | - | $616.00K(+4.6%) | $2.14M(+10.8%) |
| Jun 2017 | - | $589.00K(+20.4%) | $1.93M(+15.9%) |
| Mar 2017 | - | $489.00K(+9.9%) | $1.67M(+14.7%) |
| Dec 2016 | $1.45M(+44.0%) | $445.00K(+9.1%) | $1.45M(+13.7%) |
| Sep 2016 | - | $408.00K(+25.9%) | $1.28M(+14.7%) |
| Jun 2016 | - | $324.00K(+17.4%) | $1.11M(+7.0%) |
| Mar 2016 | - | $276.00K(+2.2%) | $1.04M(+3.2%) |
| Dec 2015 | $1.01M(+22.0%) | $270.00K(+10.7%) | $1.01M(+4.8%) |
| Sep 2015 | - | $244.00K(-2.8%) | $963.00K(+2.9%) |
| Jun 2015 | - | $251.00K(+2.9%) | $936.00K(+4.8%) |
| Mar 2015 | - | $244.00K(+8.9%) | $893.00K(+8.0%) |
| Dec 2014 | $827.00K(+23.2%) | $224.00K(+3.2%) | $827.00K(+9.0%) |
| Sep 2014 | - | $217.00K(+4.3%) | $759.00K(+6.9%) |
| Jun 2014 | - | $208.00K(+16.9%) | $710.00K(+5.3%) |
| Mar 2014 | - | $178.00K(+14.1%) | $674.00K(+0.4%) |
| Dec 2013 | $671.00K(+2.1%) | $156.00K(-7.1%) | $671.00K(-2.9%) |
| Sep 2013 | - | $168.00K(-2.3%) | $691.00K(+0.7%) |
| Jun 2013 | - | $172.00K(-1.7%) | $686.00K(+0.9%) |
| Mar 2013 | - | $175.00K(-0.6%) | $680.00K(+3.5%) |
| Dec 2012 | $657.00K(-5.3%) | $176.00K(+8.0%) | $657.00K(+5.5%) |
| Sep 2012 | - | $163.00K(-1.8%) | $623.00K(+4.2%) |
| Jun 2012 | - | $166.00K(+9.2%) | $598.00K(-1.3%) |
| Mar 2012 | - | $152.00K(+7.0%) | $606.00K(-12.7%) |
| Dec 2011 | $694.00K(-51.7%) | $142.00K(+2.9%) | $694.00K(-19.0%) |
| Sep 2011 | - | $138.00K(-20.7%) | $857.00K(-19.3%) |
| Jun 2011 | - | $174.00K(-27.5%) | $1.06M(-14.9%) |
| Mar 2011 | - | $240.00K(-21.3%) | $1.25M(-13.1%) |
| Dec 2010 | $1.44M | $305.00K(-11.1%) | $1.44M(-15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $343.00K(-4.7%) | $1.70M(-19.7%) |
| Jun 2010 | - | $360.00K(-15.9%) | $2.12M(-19.7%) |
| Mar 2010 | - | $428.00K(-24.9%) | $2.64M(-17.0%) |
| Dec 2009 | $3.18M(-58.2%) | $570.00K(-24.9%) | $3.18M(-24.0%) |
| Sep 2009 | - | $759.00K(-13.8%) | $4.18M(-22.5%) |
| Jun 2009 | - | $881.00K(-9.1%) | $5.39M(-17.2%) |
| Mar 2009 | - | $969.00K(-38.4%) | $6.51M(-14.4%) |
| Dec 2008 | $7.61M(-19.1%) | $1.57M(-20.2%) | $7.61M(-7.2%) |
| Sep 2008 | - | $1.97M(-1.5%) | $8.20M(-2.9%) |
| Jun 2008 | - | $2.00M(-3.2%) | $8.44M(-5.2%) |
| Mar 2008 | - | $2.07M(-4.6%) | $8.91M(-5.3%) |
| Dec 2007 | $9.40M(-11.0%) | $2.17M(-2.0%) | $9.40M(-4.2%) |
| Sep 2007 | - | $2.21M(-10.3%) | $9.82M(-4.1%) |
| Jun 2007 | - | $2.47M(-3.7%) | $10.24M(-2.1%) |
| Mar 2007 | - | $2.56M(-0.7%) | $10.46M(-1.0%) |
| Dec 2006 | $10.57M(+4.7%) | $2.58M(-2.0%) | $10.57M(-0.2%) |
| Sep 2006 | - | $2.63M(-2.2%) | $10.59M(+0.8%) |
| Jun 2006 | - | $2.69M(+0.9%) | $10.50M(+1.8%) |
| Mar 2006 | - | $2.67M(+2.4%) | $10.32M(+2.2%) |
| Dec 2005 | $10.09M(+42.6%) | $2.60M(+2.3%) | $10.09M(+3.3%) |
| Sep 2005 | - | $2.54M(+1.6%) | $9.77M(+4.9%) |
| Jun 2005 | - | $2.50M(+2.6%) | $9.32M(+12.5%) |
| Mar 2005 | - | $2.44M(+7.2%) | $8.28M(+16.9%) |
| Dec 2004 | $7.08M(+91.8%) | $2.28M(+8.9%) | $7.08M(+26.4%) |
| Sep 2004 | - | $2.09M(+42.5%) | $5.60M(+23.7%) |
| Jun 2004 | - | $1.47M(+18.1%) | $4.53M(+11.3%) |
| Mar 2004 | - | $1.24M(+55.6%) | $4.07M(+10.2%) |
| Dec 2003 | $3.69M(+19.2%) | $799.00K(-21.5%) | $3.69M(-2.9%) |
| Sep 2003 | - | $1.02M(+0.9%) | $3.80M(+6.6%) |
| Jun 2003 | - | $1.01M(+16.5%) | $3.57M(+9.3%) |
| Mar 2003 | - | $866.00K(-4.8%) | $3.26M(+5.4%) |
| Dec 2002 | $3.10M(+16.9%) | $910.00K(+16.2%) | $3.10M(+6.1%) |
| Sep 2002 | - | $783.00K(+11.1%) | $2.92M(+3.4%) |
| Jun 2002 | - | $705.00K(+0.7%) | $2.83M(+2.4%) |
| Mar 2002 | - | $700.00K(-4.5%) | $2.76M(+4.0%) |
| Dec 2001 | $2.65M(+20.6%) | $733.00K(+6.7%) | $2.65M(+6.1%) |
| Sep 2001 | - | $687.00K(+7.7%) | $2.50M(+5.2%) |
| Jun 2001 | - | $638.00K(+7.6%) | $2.37M(+4.5%) |
| Mar 2001 | - | $593.00K(+2.2%) | $2.27M(+3.4%) |
| Dec 2000 | $2.20M(+4.7%) | $580.00K(+3.0%) | $2.20M(-0.9%) |
| Sep 2000 | - | $563.00K(+5.0%) | $2.22M(+2.9%) |
| Jun 2000 | - | $536.00K(+3.3%) | $2.15M(+6.7%) |
| Mar 2000 | - | $519.00K(-13.5%) | $2.02M(-3.9%) |
| Dec 1999 | $2.10M(+23.5%) | $600.00K(+20.0%) | $2.10M(+10.5%) |
| Sep 1999 | - | $500.00K(+25.0%) | $1.90M(0.0%) |
| Jun 1999 | - | $400.00K(-33.3%) | $1.90M(0.0%) |
| Mar 1999 | - | $600.00K(+50.0%) | $1.90M(+11.8%) |
| Dec 1998 | $1.70M(+30.8%) | $400.00K(-20.0%) | $1.70M(0.0%) |
| Sep 1998 | - | $500.00K(+25.0%) | $1.70M(+13.3%) |
| Jun 1998 | - | $400.00K(0.0%) | $1.50M(0.0%) |
| Mar 1998 | - | $400.00K(0.0%) | $1.50M(+15.4%) |
| Dec 1997 | $1.30M(+30.0%) | $400.00K(+33.3%) | $1.30M(+8.3%) |
| Sep 1997 | - | $300.00K(-25.0%) | $1.20M(0.0%) |
| Jun 1997 | - | $400.00K(+100.0%) | $1.20M(+20.0%) |
| Mar 1997 | - | $200.00K(-33.3%) | $1.00M(0.0%) |
| Dec 1996 | $1.00M | $300.00K(0.0%) | $1.00M(+42.9%) |
| Sep 1996 | - | $300.00K(+50.0%) | $700.00K(+75.0%) |
| Jun 1996 | - | $200.00K(0.0%) | $400.00K(+100.0%) |
| Mar 1996 | - | $200.00K | $200.00K |
FAQ
- What is Neurocrine Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual D&A year-on-year change?
- What is Neurocrine Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly D&A year-on-year change?
- What is Neurocrine Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM D&A year-on-year change?
What is Neurocrine Biosciences annual depreciation & amortization?
The current annual D&A of NBIX is $27.10M
What is the all time high annual D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual depreciation & amortization is $27.10M
What is Neurocrine Biosciences annual D&A year-on-year change?
Over the past year, NBIX annual depreciation & amortization has changed by +$5.80M (+27.23%)
What is Neurocrine Biosciences quarterly depreciation & amortization?
The current quarterly D&A of NBIX is $7.60M
What is the all time high quarterly D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly depreciation & amortization is $7.60M
What is Neurocrine Biosciences quarterly D&A year-on-year change?
Over the past year, NBIX quarterly depreciation & amortization has changed by +$1.40M (+22.58%)
What is Neurocrine Biosciences TTM depreciation & amortization?
The current TTM D&A of NBIX is $28.50M
What is the all time high TTM D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM depreciation & amortization is $28.50M
What is Neurocrine Biosciences TTM D&A year-on-year change?
Over the past year, NBIX TTM depreciation & amortization has changed by +$6.00M (+26.67%)